Additionally, miR-181d has been associated with tumor suppressive effects in non-small cell lung cancer, as well as in gastric cancer through a variety of targets including PI3K/AKT, a key mediator of disease progression [23,24]. This evidence concerns the gene AKT1 and neoplasm.